# Health Canada Moves MDEL Applications Online on 1 December 2026

Health Canada's Medical Devices Compliance Program (MDCP) has issued a [**30 October 2026 bulletin**](https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/medical-devices-compliance-bulletin/updates-application-form-0292-gui-0016.html) announcing a mandatory switch to an **online Medical Device Establishment Licence (MDEL) application form (FRM-0292)** and revised guidance [**GUI-0016**](https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/directives-guidance-documents-policies/dec-guidance-medical-device-establishment-licensing-0016.html) effective **1 December 2026**, and correcting its earlier announcement about the coming-into-force date of Canada's Phase 2 MDEL regulatory amendments ([**SOR/2026-110**](https://gazette.gc.ca/rp-pr/p2/2026/2026-06-17/html/sor-dors110-eng.html)).

Health Canada had previously announced **14 December 2026** in its [17 June 2026 bulletin](https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/medical-devices-compliance-bulletin/phase-two-our-work-modernize-licensing.html). The October bulletin confirms that the registration-based date under the regulation is **1 December 2026**. Use the [current PDF form and instructions](https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/forms/medical-device-establishment-licence-application-form-instructions-0292.html) through 30 November.

## Why the Correct Date Is 1 December 2026

Under section 10 of [SOR/2026-110](https://gazette.gc.ca/rp-pr/p2/2026/2026-06-17/html/sor-dors110-eng.html) (_Regulations Amending the Medical Devices Regulations (Establishment Licences)_, P.C. 2026-550), the amendments come into force **"on the 180th day after the day on which they are registered."**

| Milestone | Date | Explanation |
| :-- | :-- | :-- |
| **Registration of SOR/2026-110** | **4 June 2026** | Statutory registration clock starts after 4 June 2026 |
| \*\*_Canada Gazette, Part II_ publication & prior bulletin \*\* | \*\* 17 June 2026\*\* | Vol. 160, No. 12 published; June 17 bulletin erroneously stated 14 December 2026 |
| **MDCP Bulletin & advance FRM-0292 / GUI-0016 issued** | **30 October 2026** | Corrects coming-into-force date and publishes advance online instructions |
| **Coming into force & mandatory online FRM-0292 switch** | **1 December 2026** | SOR/2026-110, online FRM-0292, revised GUI-0016, and transitional deadline s. 9(2) |
| **Annual Licence Review (ALR) deadline** | **Before 1 April each year** | Amended s. 46.1(1) requires holders of licences that are not suspended to file the review with current information under s. 45 |

**Pure Global calculation:** Counting exclusively after the **4 June 2026** registration date yields (30 - 4) June + 31 July + 31 Aug + 30 Sep + 31 Oct + 30 Nov + 1 Dec = 180 days—landing on **1 December 2026**. Counting 180 days from the 17 June publication date produces the date in the earlier bulletin, 14 December, which is **13 days later**.

## Operational Changes in FRM-0292 and GUI-0016

The 30 October 2026 bulletin and advance [FRM-0292 instructions](https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/forms/dec-medical-device-establishment-licence-application-form-instructions-0292.html) introduce three structural changes starting **1 December 2026**:

1.  **Email PDF submission replaced by mandatory online portal:** MDEL applications will no longer be submitted by email. Applicants must complete and submit [FRM-0292 solely online](https://forms-formulaires.alpha.canada.ca/en/id/cmtlsi5yl001301x5dqjr6yxg). For multiple manufacturers or suppliers, Health Canada provides an optional **Section 4 Excel Addendum** to complete and upload within the online portal. The October bulletin and revised GUI-0016 specify online submission. Step 7 of the advance form instructions still mentions email. Check with the MDEL unit if the filing instructions conflict.
2.  **Sections 4 and 5 reordered:** **Section 4** now collects **Manufacturers and Suppliers** (adding non-manufacturer suppliers under amended s. 45(f.1)–(f.2)), and **Section 5** now collects **Sites** (buildings where documented procedures are in place under s. 45(j)), with amendments marking removed manufacturers, suppliers, or sites as Inactive.
3.  **Signature replaced by Senior Official Acknowledgement:** **Section 6** replaces a physical or electronic signature with a typed **Acknowledgement** (position/title, name, and date) confirming the accuracy of all application details and that required documented procedures are in place. Health Canada continues to publish the senior official's name in the public MDEL database.

The revised GUI-0016 is administrative guidance. The binding changes below come from SOR/2026-110.

## Substantive Phase 2 Law Taking Effect 1 December 2026 (SOR/2026-110)

Alongside the online portal transition, SOR/2026-110 amends Part 1 of the _Medical Devices Regulations_ on **1 December 2026** in four areas:

-   **Exemption for certain foreign distributors (s. 44(4)):** Canadian importers that hold an MDEL are no longer required to verify that a foreign distributor holds an MDEL (s. 44(4)(c)). However, persons **without** an MDEL who import directly—such as retailers or healthcare facilities—remain outside that exemption and must still verify that the foreign distributor holds an MDEL.
-   **Mandatory supplier disclosure and repealed fields (s. 45):** Every applicant and annual-review filer must provide the name, address, and device classes of any non-manufacturer supplier selling devices to the establishment for importation or distribution (s. 45(f.1)–(f.2)). Medical specialty disclosures (s. 45(e)) and the previous procedure attestations (s. 45(g)–(i)) are repealed.
-   **Explicit documented procedure mandates (ss. 52(3), 58, 58.1, 59(3)–(4), 61.2(4)):** The amendments require the applicable regulated party—manufacturers, importers, and distributors for distribution records (s. 52(3)), complaints and recalls (s. 58), and Class II–IV handling, storage, delivery, installation, servicing, and corrective action as applicable (s. 58.1); manufacturers and importers for Class I and Class II–IV incident reporting (s. 59(3)–(4)); and Class II–IV medical device licence holders and importers for serious-risk foreign notification (s. 61.2(4))—to **establish, implement, and maintain** documented procedures. Under s. 45(j) and FRM-0292 Table 1, MDEL applicants and holders (importers, distributors, and Class I manufacturers) must map their applicable procedures to each Section 5 site.
-   **Supplier information for pending applications (s. 9(2)):** For an application under the previous s. 45 still undecided on **1 December 2026**, Health Canada can issue the licence only if the applicant provides the information in s. 45(f.1)–(f.2) to the Minister in the form established by the Minister **by 1 December 2026**.

## Practical Steps Before 1 December 2026 and the 1 April ALR

**Pure Global analysis:** Use the corrected **1 December 2026** date to line up the online filing switch, any pending application and the new procedure requirements. The filing changes concern establishment licences. See our [Canada MDEL and MDL overview](https://www.pureglobal.com/markets/canada/medical-device-licence-mdl-vs-mdel) for the distinction.

1.  **Confirm how to supplement a pending application.** If a decision is still pending, confirm with the MDEL unit which form and submission method to use for the supplemental supplier information. The 30 October bulletin explains the general switch to online filing. Section 9(2) sets its own requirement to provide the information in the Minister’s form by **1 December 2026**.
2.  **Use the PDF until 30 November and switch online on 1 December:** For the online filing, prepare the Section 4 manufacturer and supplier details and use the optional Excel addendum for multiple entries. The instructions call for 6-digit MDALL company IDs for Class II–IV manufacturers.
3.  **Map Section 5 sites to the procedures that apply.** Use Table 1 of the instructions to check procedures by activity and device class. The instructions say each site must be in the same country as the establishment. Update site and supplier information before the next Annual Licence Review.
4.  **Check foreign distribution channels individually.** Before applying to cancel a foreign distributor’s MDEL, confirm which customers act as importers and hold an MDEL. Follow Appendix A only once all activities that require the licence have ceased. For broader context on device classes and establishment licensing, see our [Canada market hub](https://www.pureglobal.com/markets/canada), [Health Canada glossary](https://www.pureglobal.com/glossary/health-canada-hc), and [MDEL vs. MDL overview video](https://www.pureglobal.com/videos/health-canada-mdel-mdl-device-classes-2026).

[Canonical page](https://www.pureglobal.com/news/health-canada-mdel-online-form-frm-0292-gui-0016-december-2026)
